Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (AMRX) Stock Overview

Explore Amneal Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AMRX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$17.91
$0.01(0.06%)
U.S. Market opens in 58h 46m

Amneal Pharmaceuticals, Inc. (AMRX)

Meyka AI Score

Z

Key Financials

Market Cap5.7B
P/E Ratio36.33
EPS (TTM)$0.90
ROE-3.27%
Fundamental Analysis

AI Price Forecasts

1 Month$18.02
3 Months$21.55
1 Year Target$20.10

AMRX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Amneal Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AMRX on the NASDAQ shows an RSI of 51.79, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.10 for the NASDAQ listing.

Key metrics behind Amneal Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of 36.33 and a market capitalization of 5.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AMRX on the NASDAQ.

Price Performance (NASDAQ: AMRX)

1-Day Change
0.06%
5-Day Change
4.92%
1-Month Change
-1.05%
3-Month Change
44.20%
6-Month Change
23.52%
Year-to-Date (YTD) Change
42.14%
1-Year Change
87.93%
3-Year Change
370.08%
5-Year Change
238.56%
All-Time (Max) Change
277.05%

Contact Information

https://www.amneal.com
908 947 3120
400 Crossing Boulevard, Bridgewater, NJ, 08807

Company Facts

87,000 Employees
IPO DateMay 7, 2018
CountryUS
Actively Trading

Frequently Asked Questions